Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) insider Sanjay Nayak sold 2,274 shares of Ocular Therapeutix stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $5.84, for a total value of $13,280.16. Following the sale, the insider now directly owns 178,026 shares of the company’s stock, […]
Experts weigh current, future options for AMD management healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average […]
OCUL Stock Earnings: Ocular Therapeutix Misses EPS, Misses Revenue for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.